Simplex Trading
CNTB

Simplex Trading’s Connect Biopharma Holdings CNTB Stock Holding History

Simplex Trading’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-98
Closed -$255 – 9203
2025
Q4 		$276 Buy
+98
New +$209 ﹤0.01% 8231
2024
Q2 		– Sell
-81
Closed – – 8911
2024
Q1 		$0 Buy
+81
New +$98 ﹤0.01% 8951
2023
Q1 		– Sell
-994
Closed – – 9138
2022
Q4 		$0 Buy
994
+91
+10% +$75 ﹤0.01% 9334
2022
Q3 		$1K Buy
+903
New +$1.08K ﹤0.01% 9498
2022
Q2 		– Sell
-1,255
Closed -$3K – 10074
2022
Q1 		$3K Sell
1,255
-6,977
-85% -$29.5K ﹤0.01% 9671
2021
Q4 		$42K Buy
+8,232
New +$91.5K ﹤0.01% 7469

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Simplex Trading's CNTB Position: Q1 2026 in Review

Simplex Trading sold out of Connect Biopharma Holdings (CNTB) in Q1 2026, closing a stake of 98 shares — an estimated $255 sold.

Simplex Trading first reported a position in CNTB in Q4 2021 and held it in 6 quarters. The position peaked at $42K in Q4 2021. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Simplex Trading reported no remaining Connect Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 98 Connect Biopharma Holdings shares in Q1 2026, an estimated $255.
  • Simplex Trading first reported a position in Connect Biopharma Holdings in Q4 2021 and held it in 6 quarters.
  • Simplex Trading's Connect Biopharma Holdings position peaked at $42K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.